Literature DB >> 4307092

Hypothalamo-pituitary-adrenal function in the rat after prolonged treatment with cortisol.

J R Hodges, J Sadow.   

Abstract

1. Cortisol, administered subcutaneously every day for long periods, caused growth retardation, adrenal atrophy and impaired hypothalamo-pituitary-adrenal (HPA) function in the rat.2. The growth rate and the functional activity of the HPA system gradually returned to normal after steroid withdrawal.3. Normal adrenal sensitivity to corticotrophin returned more rapidly than normal pituitary corticotrophic function, suggesting that the initial impairment of HPA function was due both to reduced responsiveness of the adrenal gland to corticotrophin and failure of the pituitary gland to secrete the hormone.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4307092      PMCID: PMC1703614          DOI: 10.1111/j.1476-5381.1969.tb08005.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy.

Authors:  T Livanou; D Ferriman; V H James
Journal:  Lancet       Date:  1967-10-21       Impact factor: 79.321

2.  EFFECT OF CORTISOL ON GROWTH AND FOOD INTAKE IN RATS.

Authors:  D BELLAMY
Journal:  J Endocrinol       Date:  1964-11       Impact factor: 4.286

3.  The estimation of small amounts of corticosterone in rat plasma.

Authors:  N ZENKER; D E BERNSTEIN
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

4.  Postoperative adrenal cortical insufficiency; occurrence in patients previously treated with cortisone.

Authors:  R M SALASSA; W A BENNETT; F R KEATING; R G SPRAGUE
Journal:  J Am Med Assoc       Date:  1953-08-15

5.  ATROPHY OF THE ADRENAL CORTEX OF THE RAT PRODUCED BY THE ADMINISTRATION OF LARGE AMOUNTS OF CORTIN.

Authors:  D J Ingle; E C Kendall
Journal:  Science       Date:  1937-09-10       Impact factor: 47.728

6.  Suppression of the pituitary-ACTH response in man by administration of ACTH or cortisol.

Authors:  J E PLAGER; P CUSHMAN
Journal:  J Clin Endocrinol Metab       Date:  1962-02       Impact factor: 5.958

7.  Adrenal atrophy and irreversible shock associated with cortisone therapy.

Authors:  C G FRASER; F S PREUSS; W D BIGFORD
Journal:  J Am Med Assoc       Date:  1952-08-23

8.  Hypothalamo-pituitary-adrenal function in patients on long-term adrenocorticotrophin therapy.

Authors:  P A Bacon; J R Daly; A B Myles; O Savage
Journal:  Ann Rheum Dis       Date:  1968-01       Impact factor: 19.103

9.  The effect of cortisol on the activity of glutamate-pyruvate transaminase and the formation of glycogen and urea in starved rats.

Authors:  D Bellamy; R A Leonard
Journal:  Biochem J       Date:  1964-11       Impact factor: 3.857

10.  The response to stress after corticosteroid therapy.

Authors:  T Livanou; D Ferriman; V H James
Journal:  Proc R Soc Med       Date:  1965-12
View more
  4 in total

1.  Hypothalamo-pituitary adrenocortical function in the rat after treatment with betamethasone.

Authors:  J C Buckingham; J R Hodges
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

2.  Corticotroph isolation from Pomc-eGFP mice reveals sustained transcriptional dysregulation characterising a mouse model of glucocorticoid-induced suppression of the hypothalamus-pituitary-adrenal axis.

Authors:  Peter J Duncan; Heather McClafferty; Oscar Nolan; Qinghui Ding; Natalie Z M Homer; Paul Le Tissier; Brian R Walker; Michael J Shipston; Nicola Romanò; Thomas J G Chambers
Journal:  J Neuroendocrinol       Date:  2022-07-14       Impact factor: 3.870

3.  Recovery of hypothalamo-pituitary-adrenal function in the rat after prolonged treatment with betamethasone.

Authors:  J R Hodges; S Mitchley
Journal:  Br J Pharmacol       Date:  1970-12       Impact factor: 8.739

4.  The effect of betamethasone on circadian and stress-induced pituitary-adrenocortical function in the rat.

Authors:  J R Hodges; S Mitchley
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.